Moringa oleifera, a multifaceted plant species indigenous to tropical and subtropical climates, has garnered considerable interest in the pharmaceutical sector as a natural excipient. This abstract examines the significance of Moringa oleifera in pharmaceutical formulations, emphasizing its ability to tackle critical difficulties in medication transport and formulation. The plant's many components, such as leaves, seeds, and bark, possess bioactive chemicals with distinct characteristics that render them appropriate for use as excipients. These features include binding, disintegration, film formation, as well as antioxidant and antibacterial activity. The use of excipients generated from Moringa oleifera has several benefits, including increased bioavailability, greater stability, and less toxicity in pharmaceutical formulations. Moreover, the plant's extensive availability, economic viability, and environmentally sustainable characteristics make it a compelling substitute for synthetic excipients. This study consolidates contemporary research on the uses of Moringa oleifera in pharmaceutical formulations, examining its potential to transform drug delivery methods and aid in the creation of more sustainable and effective treatments. The results highlight the need for more research into the pharmaceutical uses of Moringa oleifera, facilitating the development of novel medication formulations and enhanced patient outcomes.
Read full abstract